Log in to your Inderes Free account to see all free content on this page.

Novo Nordisk

272.25 DKK

+6.53%

1,024 following

NOVO B

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Novo Nordisk

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue71,311.085,683.0290,403.078,087.076,857.074,976.079,144.0309,064.0
EBITDA35,972.041,935.0147,446.042,621.038,282.031,439.037,298.0149,640.0
EBIT33,822.036,737.0128,339.038,791.033,449.023,682.031,736.0127,658.0
EBIT-%47.4 %42.9 %44.2 %49.7 %43.5 %31.6 %40.1 %41.3 %
Profit before taxes34,384.035,557.0127,191.037,033.033,805.025,517.034,185.0130,540.0
Net income27,301.028,230.0100,988.029,034.026,503.020,006.026,891.0102,434.0
Login required

This content is only available for logged in users